- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Theses and Dissertations /
- Morphological and functional studies of substance P...
Open Collections
UBC Theses and Dissertations
UBC Theses and Dissertations
Morphological and functional studies of substance P and somatostatin in the small intestine Accili, Eric Anthony
Abstract
The regulation of gastrointestinal function is partly dependent on the intrinsic neurones of the gut. Intrinsic neurones contain a large number of neurotransmitters, including neuropeptides, in different combinations. Neurones have been grouped according to the combination of neurotransmitters they contain and this practice is called chemical coding. The present studies were carried out to examine differences in chemical coding and enteric neuronal morphology in the human and canine small intestine, especially the submucosal plexus. The neuropeptides chosen for examination were substance P, somatostatin and vasoactive intestinal peptide because of their known involvement in both the physiology and pathophysiology of the small intestine. Further, primary cultures of submucosal neurones from human and canine submucosal plexus were utilized to determine whether differences in coding and morphology paralleled differences in somatostatin secretion. Substance P immunoreactivity (SP—IR), somatostatin immunoreactivity (SS-IR) and vasoactive intestinal peptide immunoreactivity (VIP-1R) have been localized and their distributions have been compared in dog and human small intestine using immunocytochemistry (ICC). An antibody to protein gene product 9.5 (PGP) was used to localize all nerve cell bodies and fibres in the dog and human upper jejunum. In addition, the proportions of peptide-containing neurones were determined by double staining. Staining with PGP revealed neuronal cell bodies in the submucosal plexus (SMP) and the myenteric plexus (MYP) as well as extensive innervation by fibres throughout all regions of the small intestine. Canine submucosal ganglia contained 7.7 ± 0.6 neurones per submucosal ganglion (184 ganglia, n = 6 dogs), while the human ganglia contained 2.9 ± 0.3 (185 ganglia counted, n = 5 donors). Over 50 % of the ganglia in the human sections contained 3 or less neurones but over 10 % of the ganglia in canine sections contained 15 or more neurones. Finally, the canine circular muscle was shown to possess a distinct deep neural plexus, in contrast to that of human circular muscle. The distribution of SPIR, SSIR and VIP-IR in canine and human jejunum was similar, confirming the results of previous studies. Double staining revealed that SP-IR and SS-IR were always co-localized in the human, but not canine, SMP and MYP. In both species VIPIR was present in a population of neurones distinct from those containing SP—IR and SS—IR. In canine ganglia, 30% of neurones per ganglion in the SMP contained SP-IR, 35% contained SSIR and 30% contained VIP-IR. In human ganglia, 42% of neurones per ganglion contained SP-IR and SSIR while 40% contained VIP IR. These results sugest different functions for SP and SS in canine and human enteric ganglia. The secretion of SSIR, from intact preparations of small intestine, is difficult to interpret for two reasons First, SS—IR has been demonstrated in vagal, submucosal and myenteric neurones as well as endocrine cells, of the small intestine. Second, enteric neurones have been shown to to contain the 14 amino acid form of SS-IR (SS-14) while endocrine cells have been shown to contain the 28 amino acid form (SS28). A dispersed culture of submucosal cells from human small intestine was developed to examine the localization, release and molecular characteristics of SS IR. After 72 h, the neurones were shown to be viable and to sprout neurites containing varicosities suggesting that they retained a morphologic phenotype similar to that observed in situ. Thirty percent of the submucosal neurones per ganglion in tissue sections and 35 % of cells per cluster in culture contained SSoIR. Acetic acid extracts of cultures contained 1990 ± 809 pg SS-IR/well. Incubation of cultures with phorbol 1213-myristate 13-acetate (13-PMA), an activator of protein kinase C (PKC), at concentrations up to M for 120 mm increased the release of SSIR up to 23 times the basal level, and up to 27 times the basal level when extracellular K+ was increased from 5 to 10 mM. Of the total SSIR released in response to 13-PMA (106 M, 10 mM K+), 59% was present in the medium after 30 iuin and 80% after 60 mm. Basal release of SS—IR could be reliably measured only after 120 mm, therefore experiments which examined somatostatin secretion were carried out for this amount of time. The release of SS-IR by 13-PMà was not due to non—specific membrane effects since the inactive 4a phorbol at the same concentrations did not alter basal release. Greater than 90 % of SS—IR present in acid extracts of cultures and released by I3PMà eluted with the same retention time as synthetic SS’14 on reverse phase high performance liquid chromatography (HPLC) In summary, the results presented in this thesis have shown that differences exist in the neuropeptide distribution and neuronal.morphology between the canine and human small intestine. Moreover, SS—IR secretion from human submucosal neurones in response to SP and the phorbol ester were found to be different from the secretion of SS—IR from canine neurones. The results suggest that differences observed in the pattern of secretion in submucosal neurones probably reflect the differences noted in neuropeptide distribution and neuronal morphology. Furthermore, the present studies emphasize that the extrapolation of experimental data between species must be made with caution.
Item Metadata
Title |
Morphological and functional studies of substance P and somatostatin in the small intestine
|
Creator | |
Publisher |
University of British Columbia
|
Date Issued |
1992
|
Description |
The regulation of gastrointestinal function is partly
dependent on the intrinsic neurones of the gut. Intrinsic
neurones contain a large number of neurotransmitters,
including neuropeptides, in different combinations.
Neurones have been grouped according to the combination of
neurotransmitters they contain and this practice is called
chemical coding. The present studies were carried out to
examine differences in chemical coding and enteric neuronal
morphology in the human and canine small intestine,
especially the submucosal plexus. The neuropeptides chosen
for examination were substance P, somatostatin and
vasoactive intestinal peptide because of their known
involvement in both the physiology and pathophysiology of
the small intestine. Further, primary cultures of
submucosal neurones from human and canine submucosal plexus
were utilized to determine whether differences in coding and
morphology paralleled differences in somatostatin secretion.
Substance P immunoreactivity (SP—IR), somatostatin
immunoreactivity (SS-IR) and vasoactive intestinal peptide
immunoreactivity (VIP-1R) have been localized and their
distributions have been compared in dog and human small
intestine using immunocytochemistry (ICC). An antibody to
protein gene product 9.5 (PGP) was used to localize all
nerve cell bodies and fibres in the dog and human upper
jejunum. In addition, the proportions of peptide-containing
neurones were determined by double staining.
Staining with PGP revealed neuronal cell bodies in the
submucosal plexus (SMP) and the myenteric plexus (MYP) as
well as extensive innervation by fibres throughout all
regions of the small intestine. Canine submucosal ganglia
contained 7.7 ± 0.6 neurones per submucosal ganglion (184
ganglia, n = 6 dogs), while the human ganglia contained 2.9
± 0.3 (185 ganglia counted, n = 5 donors). Over 50 % of the
ganglia in the human sections contained 3 or less neurones
but over 10 % of the ganglia in canine sections contained 15
or more neurones. Finally, the canine circular muscle was
shown to possess a distinct deep neural plexus, in contrast
to that of human circular muscle.
The distribution of SPIR, SSIR and VIP-IR in canine
and human jejunum was similar, confirming the results of
previous studies. Double staining revealed that SP-IR and
SS-IR were always co-localized in the human, but not canine,
SMP and MYP. In both species VIPIR was present in a
population of neurones distinct from those containing SP—IR
and SS—IR. In canine ganglia, 30% of neurones per ganglion
in the SMP contained SP-IR, 35% contained SSIR and 30%
contained VIP-IR. In human ganglia, 42% of neurones per
ganglion contained SP-IR and SSIR while 40% contained VIP
IR. These results sugest different functions for SP and SS
in canine and human enteric ganglia.
The secretion of SSIR, from intact preparations of
small intestine, is difficult to interpret for two reasons
First, SS—IR has been demonstrated in vagal, submucosal and
myenteric neurones as well as endocrine cells, of the small
intestine. Second, enteric neurones have been shown to to
contain the 14 amino acid form of SS-IR (SS-14) while
endocrine cells have been shown to contain the 28 amino acid
form (SS28). A dispersed culture of submucosal cells from
human small intestine was developed to examine the
localization, release and molecular characteristics of SS
IR. After 72 h, the neurones were shown to be viable and to
sprout neurites containing varicosities suggesting that they
retained a morphologic phenotype similar to that observed in
situ. Thirty percent of the submucosal neurones per
ganglion in tissue sections and 35 % of cells per cluster in
culture contained SSoIR. Acetic acid extracts of cultures
contained 1990 ± 809 pg SS-IR/well. Incubation of cultures
with phorbol 1213-myristate 13-acetate (13-PMA), an activator
of protein kinase C (PKC), at concentrations up to M
for 120 mm increased the release of SSIR up to 23 times
the basal level, and up to 27 times the basal level when
extracellular K+ was increased from 5 to 10 mM. Of the
total SSIR released in response to 13-PMA (106 M, 10 mM
K+), 59% was present in the medium after 30 iuin and 80%
after 60 mm. Basal release of SS—IR could be reliably
measured only after 120 mm, therefore experiments which
examined somatostatin secretion were carried out for this
amount of time. The release of SS-IR by 13-PMà was not due
to non—specific membrane effects since the inactive 4a
phorbol at the same concentrations did not alter basal
release. Greater than 90 % of SS—IR present in acid
extracts of cultures and released by I3PMà eluted with the
same retention time as synthetic SS’14 on reverse phase high
performance liquid chromatography (HPLC)
In summary, the results presented in this thesis have
shown that differences exist in the neuropeptide
distribution and neuronal.morphology between the canine and
human small intestine. Moreover, SS—IR secretion from human
submucosal neurones in response to SP and the phorbol ester
were found to be different from the secretion of SS—IR from
canine neurones. The results suggest that differences
observed in the pattern of secretion in submucosal neurones
probably reflect the differences noted in neuropeptide
distribution and neuronal morphology. Furthermore, the
present studies emphasize that the extrapolation of
experimental data between species must be made with caution.
|
Extent |
5855498 bytes
|
Genre | |
Type | |
File Format |
application/pdf
|
Language |
eng
|
Date Available |
2008-12-12
|
Provider |
Vancouver : University of British Columbia Library
|
Rights |
For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.
|
DOI |
10.14288/1.0086500
|
URI | |
Degree | |
Program | |
Affiliation | |
Degree Grantor |
University of British Columbia
|
Graduation Date |
1992-11
|
Campus | |
Scholarly Level |
Graduate
|
Aggregated Source Repository |
DSpace
|
Item Media
Item Citations and Data
Rights
For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.